The global drug
of abuse testing services market is expected to reach USD 2.9 billion
by 2025, according to a new report by Grand View Research, Inc. Increase in
demand for therapy for substance abuse is one of the crucial factors
anticipated to boost the market. According to World Drug Report 2016, annually,
treatments for drug abuse are accessible to only 17% of the total drug abusers.
In North American, Eastern & Southeastern Europe, and Asia, opioid is one
of the major drugs of concern.
According to World Drug Report 2016, 1 in every 20
people aged 15 to 64 consumed at least one drug in 2014. More than 29 million
people who abuse drugs are estimated to suffer from drug-related disorders.
There are 12 million people that abuse drugs, out of whom 14% are suffering
from HIV. Cannabis and amphetamine are some of the highly abused drugs
globally. Approximately 183 million people used cannabis in 2014. Stringent
regulations for drug abuse testing at workplaces, such as Omnibus
Transportation Employee Testing Act of 1991, etc., are expected to increase
demand for screening kits over the forecast period.
Morbidity and mortality due to drug abuse are rising
globally. One in every 4 deaths is attributed to tobacco, alcohol, and illicit
drug consumption. The overdose of opioids results in adverse and serious health
conditions. In the U.S., the nonmedical use of prescription opioids has
considerably increased. According to statistics reported by National Institute
of Drug Abuse, overdose of opioids results in more than 90 deaths every day in
the U.S. The rise in prevalence of comorbidities associated with substance
abuse, such as HIV and hepatitis C, have resulted in increase in demand for
screening procedures. Furthermore, increase in the number of government
initiatives to control illicit drugs and alcohol usage and rise in number of
treatment alternatives are also driving the market.
Browse full research report on Global Drug of Abuse Testing Services Market: https://www.grandviewresearch.com/industry-analysis/drugs-abuse-testing-services-market
Further Key Findings From the Report Suggest:
- The global drug of abuse testing services market size was estimated
at USD 1,465.4 million in 2016 and is expected to grow at a CAGR of 8.1%
from 2017 to 2025
- Cannabis emerged as the largest drug type segment and the opioids
segment is anticipated to witness fastest growth over the next 8 years
- The North America region accounted for the largest market share in
2016 due to increased usage of medical marijuana, increased usage of
investigational testing, and rise in number of toxicology laboratories.
- Asia Pacific is anticipated to witness lucrative growth over the
next decade due to increase in alcohol consumption and related disorders
in this region
- The market is highly consolidated in the U.S., with Laboratory
Corporation of America Holdings; Alere; United States Drug Testing
Laboratories, Inc. (USDTL); Quest Diagnostics, Inc. holding 85% market
share.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand
View Research has segmented the drug of abuse testing services market on the
basis of drug type and region:
Drug
Type Outlook (Revenue, USD Million, 2014 - 2025)
- Alcohol
- Cannabis
- Cocaine
- Opioids
- Amphetamine
- LSD
Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Chile
- Mexico
- Middle East
& Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment